3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Ovarian Neoplasms
44
Lung Neoplasms
29
Neuroblastoma
24
Small Cell Lung Carcinoma
21
Carcinoma, Ovarian Epithelial
19
Fallopian Tube Neoplasms
17
Neoplasms
14
Brain Neoplasms
14
Uterine Cervical Neoplasms
11
Leukemia, Myeloid, Acute
11
Leukemia
11
Retinoblastoma
10
Glioma
9
Recurrence
8
Sarcoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma
7
Central Nervous System Neoplasms
7
Sarcoma, Ewing
6
Neoplasm Metastasis
6
Lymphoma, Follicular
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Osteosarcoma
5
Gliosarcoma
5
Glioblastoma
5
Endometrial Neoplasms
5
Burkitt Lymphoma
5
Blast Crisis
5
Astrocytoma
5
Wilms Tumor
4
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Topotecan
1
Tobramycin
1
Thrombin
1
TachoSil
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Music Therapy
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Gemcitabine
1
Fosfomycin
1
Dialectical Behavior Therapy
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Meningitis
×
Topotecan
×
Clear all
NCT00674674
2012-05-15
PBTC-019
Baylor College of Medicine
Phase 1
Completed
22 enrolled